The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Sean D. Sullivan

Pharmaceutical

Outcomes Research and Policy Program

University of Washington

Seattle

USA

[email]@u.washington.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Pharmaceutical, Outcomes Research and Policy Program, University of Washington, Seattle, USA. 2000 - 2009
  • University of Washington, Seattle, Washington 98195, USA. 2004 - 2009

References

  1. Long-term outcomes in patients with type 2 diabetes receiving glimepiride combined with liraglutide or rosiglitazone. Sullivan, S.D., Alfonso-Cristancho, R., Conner, C., Hammer, M., Blonde, L. Cardiovasc. Diabetol (2009) [Pubmed]
  2. A simulation of the comparative long-term effectiveness of liraglutide and glimepiride monotherapies in patients with type 2 diabetes mellitus. Sullivan, S.D., Alfonso-Cristancho, R., Conner, C., Hammer, M., Blonde, L. Pharmacotherapy (2009) [Pubmed]
  3. Health technology assessment in health-care decisions in the United States. Sullivan, S.D., Watkins, J., Sweet, B., Ramsey, S.D. Value. Health (2009) [Pubmed]
  4. The promise of specialty pharmaceuticals: are they worth the price? Sullivan, S.D. J. Manag. Care. Pharm (2008) [Pubmed]
  5. Cost-effectiveness of peginterferon alpha-2a compared to lamivudine treatment in patients with hepatitis B e antigen positive chronic hepatitis B in Taiwan. Sullivan, S.D., Veenstra, D.L., Chen, P.J., Chang, T.T., Chuang, W.L., Tsai, C., Patel, K. J. Gastroenterol. Hepatol. (2007) [Pubmed]
  6. Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery. Sullivan, S.D., Kwong, L., Nutescu, E. Value. Health (2006) [Pubmed]
  7. A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II). Sullivan, S.D., Lee, T.A., Blough, D.K., Finkelstein, J.A., Lozano, P., Inui, T.S., Fuhlbrigge, A.L., Carey, V.J., Wagner, E., Weiss, K.B. Arch. Pediatr. Adolesc. Med (2005) [Pubmed]
  8. Cost effectiveness of peginterferon alpha-2a plus ribavirin versus interferon alpha-2b plus ribavirin as initial therapy for treatment-naive chronic hepatitis C. Sullivan, S.D., Craxi, A., Alberti, A., Giuliani, G., De Carli, C., Wintfeld, N., Patel, K.K., Green, J. Pharmacoeconomics (2004) [Pubmed]
  9. A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery. Sullivan, S.D., Davidson, B.L., Kahn, S.R., Muntz, J.E., Oster, G., Raskob, G. Pharmacoeconomics (2004) [Pubmed]
  10. Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery. Sullivan, S.D., Kahn, S.R., Davidson, B.L., Borris, L., Bossuyt, P., Raskob, G. Pharmacoeconomics (2003) [Pubmed]
  11. Exploring new frontiers in asthma management for optimal therapeutic and economic outcomes. Sullivan, S.D., Meltzer, E.O. J. Manag. Care. Pharm (2003) [Pubmed]
  12. Asthma in the United States: recent trends and current status. Sullivan, S.D. J. Manag. Care. Pharm (2003) [Pubmed]
  13. Emerging therapeutic strategies for asthma management. Sullivan, S.D., Meltzer, E.O. J. Manag. Care. Pharm (2003) [Pubmed]
  14. Health state preference assessment in diabetic peripheral neuropathy. Sullivan, S.D., Lew, D.P., Devine, E.B., Hakim, Z., Reiber, G.E., Veenstra, D.L. Pharmacoeconomics (2002) [Pubmed]
  15. The economic burden of COPD. Sullivan, S.D., Ramsey, S.D., Lee, T.A. Chest (2000) [Pubmed]
 
WikiGenes - Universities